Sodium Glucose Co-Transporter 2 inhibitors SGLT2 inhibitors - Citywide Guideline for the Safe and Appropriate Use of

Publication: 27/04/2022  
Next review: 27/04/2025  
Best Practice Document
CURRENT 
ID: 7471 
Approved By: LAPC 
Copyright© Leeds Teaching Hospitals NHS Trust 2022  

 

This Best Practice Document is intended for use by healthcare professionals within Leeds unless otherwise stated.
For healthcare professionals in other trusts, please ensure that you consult relevant local and national guidance.

Citywide Guideline for the Safe and Appropriate Use of Sodium Glucose Co-Transporter 2 inhibitors SGLT2 inhibitors

Provenance

Record: 7471
Objective:
Clinical condition:
Target patient group:
Target professional group(s): Pharmacists
Primary Care Doctors
Secondary Care Doctors
Adapted from:

Evidence base

Not supplied

Approved By

LAPC

Document history

LHP version 1.0

Related information

Not supplied